– the leading provider of online annual reports to individual and institutional investors.

Aradigm Corp.

Aradigm Corporation, a pharmaceutical company, engages in the development and commercialization of drugs delivered by inhalation for the treatment of respiratory diseases by pulmonologists in the United States. The company’s activities include development programs addressing the treatment of cystic fibrosis, bronchiectasis, pulmonary arterial hypertension, chronic obstructive pulmonary disease, inhalation anthrax infections, and smoking cessation.

No investor fact sheets added yet
No responsibility reports added yet

Browse Reports